Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Share-based Compensation (2016 - 2018)

Armata Pharmaceuticals' Share-based Compensation history spans 6 years, with the latest figure at -$1000.0 for Q4 2018.

  • For Q4 2018, Share-based Compensation rose 97.96% year-over-year to -$1000.0; the TTM value through Dec 2018 reached $46000.0, down 91.14%, while the annual FY2024 figure was $2.9 million, 208.42% up from the prior year.
  • Share-based Compensation for Q4 2018 was -$1000.0 at Armata Pharmaceuticals, down from $8000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.4 million in Q3 2014 and bottomed at -$83000.0 in Q2 2018.
  • The 5-year median for Share-based Compensation is $122000.0 (2018), against an average of $227470.6.
  • The largest annual shift saw Share-based Compensation surged 1469.23% in 2016 before it plummeted 127.76% in 2018.
  • A 5-year view of Share-based Compensation shows it stood at $61000.0 in 2014, then skyrocketed by 144.26% to $149000.0 in 2015, then skyrocketed by 99.33% to $297000.0 in 2016, then plummeted by 116.5% to -$49000.0 in 2017, then soared by 97.96% to -$1000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Share-based Compensation are -$1000.0 (Q4 2018), $8000.0 (Q3 2018), and -$83000.0 (Q2 2018).